Literature DB >> 10749385

Substance use and HIV risk profile of gay/bisexual males who drop out of substance abuse treatment.

G M Crosby1, R D Stall, J P Paul, D C Barrett.   

Abstract

This analysis was undertaken to identify (a) the level of HIV sexual risk behaviors of men who drop out of treatment and (b) baseline variables associated with later treatment dropout. A cross-sectional sample of 340 gay/bisexual men were recruited from an outpatient substance abuse treatment facility in San Francisco. We compared participants who completed less than 15 visits with participants who graduated from the program. Men who dropped out were more likely than treatment graduates to report injection drug use, social problems related to substance use, self-blaming coping strategies, and more recent substance use prior to entering treatment and less likely to have a college degree, report using sex for tension relief, and have previously attended Alcoholics Anonymous or Narcotics Anonymous. Given the strong link between the substance abuse and HIV epidemics, substance abuse treatment agencies have been forced into addressing the issues of HIV sexual risk taking with their clients. Strategies toward reducing substance use relapse and HIV risk reduction are offered.

Entities:  

Mesh:

Year:  2000        PMID: 10749385

Source DB:  PubMed          Journal:  AIDS Educ Prev        ISSN: 0899-9546


  2 in total

1.  Longitudinal patterns of methamphetamine, popper (amyl nitrite), and cocaine use and high-risk sexual behavior among a cohort of san francisco men who have sex with men.

Authors:  Grant Colfax; Thomas J Coates; Marla J Husnik; Yijian Huang; Susan Buchbinder; Beryl Koblin; Margaret Chesney; Eric Vittinghoff
Journal:  J Urban Health       Date:  2005-02-28       Impact factor: 3.671

2.  A latent class approach to treatment readiness corresponds to a transtheoretical ("Stages of Change") model.

Authors:  Paul Truman Harrell; R C Trenz; M Scherer; S S Martins; W W Latimer
Journal:  J Subst Abuse Treat       Date:  2013-05-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.